Sk Biopharmaceuticals Co., Ltd. (326030)
Market Closed
11 Aug, 06:30
KRX SM KRX SM Primary ₩
90,600. 00
+1,900
+2.1421%
₩
10.95T Market Cap
- P/E Ratio
- Div Yield
31,193 Volume
566.84 Eps
₩ 88,700
Previous Close Want to track 326030 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sk Biopharmaceuticals Co., Ltd. (326030) Statistics
Valuation metrics
Market Cap 10.95T
Enterprise value 6.43T
Trailing P/E (ttm) 17.27
Forward P/E -
PEG ratio 0.33
Price/Sales (ttm) 7.76
Price/Book (mrq) 7.18
Enterprise Value/Revenue 7.46
Enterprise Value/EBITDA 27.71
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 145K
Average volume (90 days) 270.67K
Price summary
52-Week low 73,000
52-Week high 144,100
Beta -
50-Day moving average 81,977.14
200-Day moving average 96,582.59
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.47%
Operating margin 0.35%
Operational effectiveness
Return on assets 0.3%
Return on equity 0.53%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 10,998.68
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 5,119.92
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3,969.47
Total debt (mrq) -
Total Debt/Equity (mrq) 0.05
Current ratio (mrq) 2.49%
Book value per share (mrq) 11,901.63
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
